About David Zacardelli
Form D filings for Elucida Oncology from 2022 to 2023 list David Zacardelli as director.
David Zacardelli first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name David Zacardelli in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Zacardelli works with at each company, as listed on that company's latest Form D.
Elucida Oncology, Inc. · Form D/A, Aug 3, 2023
TB
Tim Boris
Director
RR
Robert Ruffolo
Director
UW
Ulrich Wiesner
Director
GS
Gary Sender
Director
RE
Robert Essner
Executive officer and director
NM
Natalie MacDonald
Director
GG
Geno Germano
CEO and director